JUL 05, 2021 7:29 AM PDT

ADHD Drug Reduces Daydreaming, Fatigue and Boredom

WRITTEN BY: Annie Lennon

Researchers led by New York University have found that a stimulant drug may be able to treat persistent daydreaming, fatigue, and brain sluggishness, also known as sluggish cognitive tempo (SCT). The study was published in The Journal of Clinical Psychiatry.

The drug, known as lisdexamfetamine and sold as Vyvanse, is a central nervous system stimulant. It works by blocking the reabsorption of norepinephrine and dopamine in the presynaptic neuron, and thus increasing concentrations of these neurotransmitters between neurons.

In particular, the drug increases levels of norepinephrine and dopamine in the prefrontal cortex, an area of the brain responsible for executive functioning, and the striatum, a part of the brain that plays a role in decision-making, motivation, and reinforcement. While these changes are thought to promote behavioral changes, how exactly the drug works to alleviate symptoms of ADHD is unknown.

For the study, the researchers recruited 38 adults diagnosed with ADHD and SCT between 2016 and 2018. They assessed each participant for symptoms of both disorders as well as executive function deficits and functional impairment at baseline, and weekly throughout the study period.

For 4 weeks, participants either took lisdexamfetamine or an inactive placebo daily. Then, after a 2-week washout, the treatments were switched between the groups.

In the end, the researchers found that lisdexamfetamine reduced symptoms of self-reported SCT by 30%. The drug also reduced symptoms of ADHD by 40%, and significantly improved executive brain function. Participants reported fewer episodes of procrastination, improved focus, and feeling able to prioritize better.

The researchers also found that a quarter of the improvements in SCT, including feelings of boredom and signs of confusion, came from reduced symptoms of ADHD. This, they say, means that improvements in ADHD symptoms of impulsivity, staying focused, and restlessness were linked to some, but not all, changes in SCT.

The study may have implications for treating adults with ADHD and SCT. This is because, according to Lenard Adler, lead author of the study, stimulant drugs have only been shown to improve symptoms of SCT in children with ADHD until now. Further studies however are needed to confirm whether stimulant drugs such as lisdexamfetamine can treat ADHD in adults.

 

Sources: The Journal of Clinical Psychiatry, Drugbank Online, Science Daily

 

About the Author
  • Science writer with a keen interest in behavioral biology, consciousness medicine and technology. Her current focus is how the interplay of these fields can create meaningful interactions, products and environments.
You May Also Like
APR 22, 2021
Drug Discovery & Development
mRNA Covid Vaccines May Protect Against New Strains and Common Cold
APR 22, 2021
mRNA Covid Vaccines May Protect Against New Strains and Common Cold
Researchers from Johns Hopkins have found that the mRNA Covid vaccines developed by Pfizer and Moderna not only work wit ...
APR 24, 2021
Drug Discovery & Development
Lithium Treats Intellectual Disabilities in Mice
APR 24, 2021
Lithium Treats Intellectual Disabilities in Mice
Mouse models of Bardet-Biedl Syndrome (BBS) have a challenge with learning as a result of dysfunctional neuronal systems ...
MAY 06, 2021
Drug Discovery & Development
Are Hallucinations Necessary for Psychedelics to Treat Depression?
MAY 06, 2021
Are Hallucinations Necessary for Psychedelics to Treat Depression?
Many who work with psychedelics say that hallucinations, or psychedelic experiences, are an integral part of psychedelic ...
JUN 14, 2021
Health & Medicine
Another Benefit of Aspirin: Decreased Colorectal Cancer Risk When Started Early
JUN 14, 2021
Another Benefit of Aspirin: Decreased Colorectal Cancer Risk When Started Early
Valued for stroke and heart attack prevention, aspirin is also recommended for colorectal cancer prevention. A Harv ...
JUL 11, 2021
Drug Discovery & Development
Antibiotic Resistance May Be Passed Between Dogs and Owners
JUL 11, 2021
Antibiotic Resistance May Be Passed Between Dogs and Owners
Household pets may act as a reservoir for mcr-1, a gene that is resistant to a last-resort antibiotic, colistin. The fin ...
JUL 12, 2021
Drug Discovery & Development
Testosterone Supplements Reduce Heart Attack and Stroke Risk
JUL 12, 2021
Testosterone Supplements Reduce Heart Attack and Stroke Risk
Taking testosterone supplements significantly reduces risk of heart attack and stroke among men with low levels of the h ...
Loading Comments...